Galderma Continues Global Growth Ambition With Sculptra (injectable poly-L-lactic Acid) Re-launch in Europe
Galderma Continues Global Growth Ambition With Sculptra (injectable poly-L-lactic Acid) Re-launch in Europe Updated protocol allows for faster and more convenient administration of Sculptra with the optional addition of lidocaine to increase patient comfort Update is based on new data from physiochemical and clinical studies evaluating the safety and effectiveness of Sculptra Virtual event held with European healthcare professionals to mark re-launch provided additional education and support on new protocol Galderma today announced a European re-launch of Sculptra (injectable poly-L-lacti...
Source: finanznachrichten.de